Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2004 | Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers | Lee, Y. C.; Wu, C. T.; Shih, J. Y.; Jou, Y. S.; Chang, Y. L. | BRITISH JOURNAL OF CANCER 90, 2378-2383 | | | |
2007 | Genome-Wide Scan for Quantitative ACE Activity in Taiwan Young-Onset Hypertension Study | Wang, R. Y.; Chung, C. M.; Fann, C. S. J.; Yang, H. C.; Chen, J. W.; Jong, Y. S.; Jou, Y. S.; Lo, H. M.; Ho, F. M.; Kang, C. S.; Chen, C. C.; Chang, H. C.; Shyue, S. K.; Pan, W. P. | HUMAN HEREDITY 65(2), 85-90 | | | |
2000 | Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis | Shen, C. Y.; Yu, J. C.; Lo, Y. L.; Kuo, C. H.; Yue, C. T.; Jou, Y. S.; Huang, C. S.; Lung, J. C.; Wu, C. W. | Cancer Res 60, 3884-3892 | | | |
2005 | Genomewide loss of heterozygosity and its clinical associations in nonsmall cell lung cancer | Tseng, R. C.; Chang, J. W.; Hsien, F. J.; Chang, Y. H.; Hsiao, C. F.; Chen, J. T.; Chen, C. Y.; Jou, Y. S.; Wang, Y. C. | Int J Cancer 117, 241-247 | | | |
2007 | High Dimension Low Sample Size Perspectives in Constrained Statistical Inference: The SARSCoV RNA Genome in Illustration | Sen, P. K.; Tsai, M. T.; Jou, Y. S. | Journal of the American Statistical Association 102, 686-694 | | | |
1996 | Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH | Burke, J. R.; Enghild, J. J.; Martin, M. E.; Jou, Y. S.; Myers, R. M.; Roses, A. D.; Vance, J. M.; Strittmatter, W. J. | Nat Med 2, 347-350 | | | |
1997 | Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer | Bell, S. M.; Shaw, M.; Jou, Y. S.; Myers, R. M.; Knowles, M. A. | Genomics 44, 163-170 | | | |
1995 | Inhibition of gap junctional intercellular communication and malignant transformation of rat liver epithelial cells by neu oncogene | Jou, Y. S.; Layhe, B.; Matesic, D. F.; Chang, C. C.; de Feijter, A. W.; Lockwood, L.; Welsch, C. W.; Klaunig, J. E.; Trosko, J. E. | Carcinogenesis 16, 311-317 | | | |
2008 | Involvement of microtubule-associated protein (MAP2) in oral cancer cell motility: a novel biological function of MAP2 in non-neuronal cell | Liu, S. Y.; Chen, Y. T.; Tseng, M. Y.; Hung, C. C.; Chiang, W. F.; Chen, H. R.; Shieh, T. Y.; Chen, C. H.; Jou, Y. S.; Chen, J. Y. | Biochem Biophys Res Commun 366(2), 520-525 | | | |
2000 | Linkage analysis with candidate genes: the Taiwan young-onset hypertension genetic study | Pan, W. H.; Chen, J. W.; Fann, C.; Jou, Y. S.; Wu, S. Y. | Hum Genet 107, 210-215 | | | |
2005 | Lipoprotein Lipase Gene is Linked and Associated with Hypertension inTaiwan Young-onset Hypertension Genetic Study | Chen, P.; Jou, Y. S.; Fann, C. S.; Chen, J. W.; Wu, S. Y.; Pan, W. H. | J Biomed Sci 12, 651-658 | | | |
2009 | Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides | Chen, P.; Jou, Y. S.; Fann, C. S. J.; Chen, J. W.; Chung, C. M.; Lin, C. Y.; Wu, S. Y.; Kang, M. J.; Chen, Y. C.; Jong, Y. S.; Lo, M. H.; Kang, C. S.; Chen, C. C.; Chang, H. C.; Huang, N. K.; Wu, Y. L.; Pan, W. H. | Hum Mutat 30(1), 49-55 | | | |
1994 | Localization of the alpha 2-macroglobulin receptor-associated protein 1 gene (LRPAP1) and other gene fragments to human chromosome 4p16.3 by direct cDNA selection | Jou, Y. S.; Goold, R. D.; Myers, R. M. | Genomics 24, 410-413 | | | |
2002 | Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer | Ho, W. L.; Chang, J. W.; Tseng, R. C.; Chen, J. T.; Chen, C. Y.; Jou, Y. S.; Wang, Y. C. | Cancer Detect Prev 26, 343-349 | | | |
2002 | Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients | Chen, Y. H.; Lin, S. J.; Lin, M. W.; Tsai, H. L.; Kuo, S. S.; Chen, J. W.; Charng, M. J.; Wu, T. C.; Chen, L. C.; Ding, Y. A.; Pan, W. H.; Jou, Y. S.; Chau, L. Y. | Hum Genet 111, 1-8 | | | |
2005 | Molecular genetic evidence supporting a novel human hepatocellularcarcinoma tumor suppressor locus at 13q12.11 | Chen, C. F.; Yeh, S. H.; Chen, D. S.; Chen, P. J.; Jou, Y. S. | Genes Chromosomes Cancer 44, 320-328 | | | |
2007 | More evidence supports the association of PPP3CC with schizophrenia | Liu, Y. L.; Fann, C. S.; Liu, C. M.; Chang, C. C.; Yang, W. C.; Hung, S. I.; Yu, S. L.; Hwang, T. J.; Hsieh, M. H.; Liu, C. C.; Tsuang, M. M.; Wu, J. Y.; Jou, Y. S.; Faraone, S. V.; Tsuang, M. T.; Chen, W. J.; Hwu, H. G. | Mol Psychiatry 12(10), 966-974 | | | |
2007 | OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci | Su, W. H.; Chao, C. C.; Yeh, S. H.; Chen, D. S.; Chen, P. J.; Jou, Y. S. | Nucleic Acids Res 35, D727-731 | | | |
2010 | Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma | Chen, C. F.; Hsu, E. C.; Lin, K. Y.; Tu, P. H.; Chang, H. W.; Lin, C. H.; Chen, Y. J.; Gu, D. L.; Lin, C. H.; Wu, J. Y.; Chen, Y. T.; Hsu, M. Y.; Jou, Y. S. | HEPATOLOGY 52(5), 1690-1701 | | | |
2008 | RASD2, MYH9, and CACNG2 Genes at Chromosome 22q12 Associated with the Subgroup of Schizophrenia with Non-deficit in Sustained Attention and Executive Function | Liu, Y. L.; Fann, C. S. J.; Liu, C. M.; Chen, W. J.; Wu, J. Y.; Hung, S. I.; Chen, C. H.; Jou, Y. S.; Liu, S. K.; Hwang, T. J.; Hsieh, M. H.; Chang, C. C.; Yang, W. C.; Lin, J. J.; Chou, F. H. C.; Faraone, S. V.; Tsuang, M. T.; Hwu, H. G. | Biological Psychiatry 64 (9), 789–796 | | | |